Published in Catheter Cardiovasc Interv on February 01, 2009
Revascularization of the impenetrable CTO--in support of enhanced antegrade approach. Catheter Cardiovasc Interv (2009) 0.75
Transapical minimally invasive aortic valve implantation: multicenter experience. Circulation (2007) 2.58
Randomized comparison between intracoronary beta-radiation brachytherapy and implantation of paclitaxel-eluting stents for the treatment of diffuse in-stent restenosis. Radiother Oncol (2006) 1.94
Direct intramyocardial plasmid vascular endothelial growth factor-A165 gene therapy in patients with stable severe angina pectoris A randomized double-blind placebo-controlled study: the Euroinject One trial. J Am Coll Cardiol (2005) 1.92
Differential effect of ischaemic preconditioning on mobilisation and recruitment of haematopoietic and mesenchymal stem cells in porcine myocardial ischaemia-reperfusion. Thromb Haemost (2010) 1.58
2-year results of the AUTAX (Austrian Multivessel TAXUS-Stent) registry beyond the SYNTAX (synergy between percutaneous coronary intervention with TAXUS and cardiac surgery) study. JACC Cardiovasc Interv (2009) 1.48
The salvage potential of coronary sinus interventions: meta-analysis and pathophysiologic consequences. J Thorac Cardiovasc Surg (2004) 1.45
Transplant coronary artery disease: Incidence, progression and interventional revascularization. Int J Cardiol (2005) 1.41
Short- and long-term results of emergency and elective percutaneous interventions on left main coronary artery stenoses. Catheter Cardiovasc Interv (2002) 1.40
Serial noninvasive in vivo positron emission tomographic tracking of percutaneously intramyocardially injected autologous porcine mesenchymal stem cells modified for transgene reporter gene expression. Circ Cardiovasc Imaging (2008) 1.34
Intracoronary thrombectomy with the X-sizer catheter system improves epicardial flow and accelerates ST-segment resolution in patients with acute coronary syndrome: a prospective, randomized, controlled study. Circulation (2002) 1.25
Combined delivery approach of bone marrow mononuclear stem cells early and late after myocardial infarction: the MYSTAR prospective, randomized study. Nat Clin Pract Cardiovasc Med (2008) 1.20
Role of adult bone marrow stem cells in the repair of ischemic myocardium: current state of the art. Exp Hematol (2008) 1.05
Multicenter assessment of coronary allograft vasculopathy by intravascular ultrasound-derived analysis of plaque composition. Nat Clin Pract Cardiovasc Med (2008) 1.01
Arterial compliance: a diagnostic marker for atherosclerotic plaque burden? Am J Hypertens (2003) 0.95
Attainment of local drug delivery with paclitaxel-eluting balloon in porcine coronary arteries. Coron Artery Dis (2008) 0.94
Small vessel stenting with cobalt-chromium stents (Arthos Pico) in a real world setting. Coron Artery Dis (2007) 0.91
Volumetric intravascular ultrasound imaging to illustrate the extent of coronary plaque burden in type 2 diabetic patients. J Diabetes Complications (2007) 0.88
Association between plasmin activation system and intravascular ultrasound signs of plaque instability in patients with unstable angina and non-st-segment elevation myocardial infarction. Am Heart J (2004) 0.87
Electromechanical properties of perfusion/metabolism mismatch: comparison of nonfluoroscopic electroanatomic mapping with 18F-FDG PET. J Nucl Med (2004) 0.86
Active endothelin is an important vasoconstrictor in acute coronary thrombi. Thromb Haemost (2007) 0.85
A randomised, double-blind, placebo-controlled, multicentre study of the safety and efficacy of BIOBYPASS (AdGVVEGF121.10NH) gene therapy in patients with refractory advanced coronary artery disease: the NOVA trial. EuroIntervention (2011) 0.84
Time course of prothrombotic and proinflammatory substance release after intracoronary stent implantation. Thromb Haemost (2008) 0.83
Clinical and angiographic analysis with a cobalt alloy coronary stent (driver) in stable and unstable angina pectoris. Am J Cardiol (2006) 0.83
Effect of intramyocardial delivery of autologous bone marrow mononuclear stem cells on the regional myocardial perfusion. NOGA-guided subanalysis of the MYSTAR prospective randomised study. Thromb Haemost (2010) 0.82
Myocardial protection via the coronary sinus. Circ J (2008) 0.81
Mechanism of lumen gain during coronary stent deployment in diabetic patients compared with non-diabetic patients. Coron Artery Dis (2002) 0.80
Characterization of hibernating myocardium with NOGA electroanatomic endocardial mapping. Am J Cardiol (2005) 0.80
Implantation of paclitaxel-eluting stent impairs the vascular compliance of arteries in porcine coronary stenting model. Atherosclerosis (2008) 0.79
Detection of high-grade stenoses with multislice computed tomography in heart transplant patients. J Heart Lung Transplant (2008) 0.78
Usefulness of intravascular ultrasound-guided histological measurements after stenting in porcine coronary artery. Coron Artery Dis (2002) 0.78
Platelet activation and high tissue factor level predict acute stent thrombosis in pig coronary arteries: prothrombogenic response of drug-eluting or bare stent implantation within the first 24 hours. Thromb Haemost (2006) 0.78
Prevention of stent thrombosis following brachytherapy and implantation of drug-eluting stents. J Interv Cardiol (2002) 0.77
Geographical miss during intracoronary irradiation: impact on restenosis and determination of required safety margin length. J Am Coll Cardiol (2002) 0.77
Vascular remodeling in atherosclerotic femoral arteries: three-dimensional US analysis. Radiology (2004) 0.77
Plasma levels of IL-6 correlate with hemodynamic abnormalities in acute pancreatitis in rabbits. Intensive Care Med (2002) 0.77
Short- and long-term clinical outcome after various stent implantation: overview of the results of uni- and multicenter stent registries. Catheter Cardiovasc Interv (2004) 0.77
Clinical quality assurance for endovascular brachytherapy devices. Radiother Oncol (2004) 0.76
Comparison of short- and long-term results of drug-eluting vs. bare metal stenting in the porcine internal carotid artery. J Endovasc Ther (2011) 0.76
Inhibition of interleukin-1beta convertase is associated with decrease of neointimal hyperplasia after coronary artery stenting in pigs. Mol Cell Biochem (2003) 0.76
Cost-effectiveness of percutaneous coronary intervention with drug-eluting stents in patients with multivessel coronary artery disease compared to coronary artery bypass surgery five-years after intervention. Catheter Cardiovasc Interv (2014) 0.75
Predictors of survival in unselected patients with acute myocardial infarction requiring continuous catecholamine support. Resuscitation (2002) 0.75
Basic treatment planning parameters for a 90Sr / 90Y source train used in endovascular brachytherapy. Z Med Phys (2004) 0.75
Drug-eluting introducer sheath prevents local peripheral complications: pre-clinical evaluation of nitric oxide-coated sheath. JACC Cardiovasc Interv (2011) 0.75
Case-based distance measurements for the selection of controls in case-matched studies: application in coronary interventions. Artif Intell Med (2002) 0.75
Intimal hyperplasia and coronary flow reserve after heart transplantation: association with big endothelin-1. J Heart Lung Transplant (2002) 0.75
Valvuloplasty with a paclitaxel-eluting balloon prevents restenosis in an experimental animal model of aortic stenosis. J Heart Valve Dis (2014) 0.75
Randomized blinded clinical trial of intracoronary brachytherapy with 90Sr/Y beta-radiation for the prevention of restenosis after stent implantation in native coronary arteries in diabetic patients. Radiother Oncol (2005) 0.75
Effects of radial stretch on target lesion revascularization after percutaneous coronary intervention: an intravascular ultrasound study. Can J Cardiol (2003) 0.75
Paradoxical effects of aurintricarboxylic acid and RG-13577: acute thrombosis and in-stent stenosis in a passive-coated stent. J Endovasc Ther (2006) 0.75
Estimation of doses to personnel and patients during endovascular brachytherapy applications. Radiat Prot Dosimetry (2004) 0.75
Serial intravascular ultrasonographic measurements after implantation of biodegradable polymer-coated stents in porcine coronary arteries. Coron Artery Dis (2003) 0.75
Clopidogrel pretreatment abolishes increase of PAI-1 after coronary stent implantation. Thromb Res (2008) 0.75
Determination and application of the reference isodose length (RIL) for commercial endovascular brachytherapy devices. Radiother Oncol (2002) 0.75
Association between the efficacy of dual antiplatelet therapy and the development of in-stent neointimal hyperplasia in porcine coronary arteries. Coron Artery Dis (2008) 0.75
[Long-term results of percutaneous transmyocardial laser revascularization therapy at the University of Vienna Medical Center]. Wien Klin Wochenschr (2004) 0.75
Increased dosage during intracoronary irradiation due to overlapped source stepping shows no long-term adverse changes in vessel morphology. J Interv Cardiol (2004) 0.75
Duration of development of symptomatic in-stent restenosis correlates with the stent-to-vessel-diameter ratio: an intravascular ultrasound study. Coron Artery Dis (2007) 0.75
Intracoronary brachytherapy with beta-radiation for the treatment of long diffuse in-stent restenosis. Coron Artery Dis (2004) 0.75
Quality assurance in intracoronary brachytherapy. Recommendations for determining the planning target length to avoid geographic miss. Radiother Oncol (2004) 0.75
Vascular morphometric changes after radioactive stent implantation: a dose-response analysis. J Am Coll Cardiol (2002) 0.75